DA
AMGN icon

DCF Advisers’s Amgen AMGN Stock Holding History

DCF Advisers’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3,000
Closed -$982K – 87
2025
Q4 		$982K Buy
3,000
+1,000
+50% +$317K 0.26% 68
2025
Q3 		$564K Buy
+2,000
New +$580K 0.18% 80
2023
Q3 		– Sell
-4,000
Closed -$888K – 97
2023
Q2 		$888K Sell
4,000
-400
-9% -$92.8K 0.47% 41
2023
Q1 		$1.06M Buy
+4,400
New +$1.08M 0.65% 34

Other funds holding AMGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

DCF Advisers's AMGN Position: Q2 2026 in Review

DCF Advisers reduced its Amgen (AMGN) stake by 13% in Q2 2026, selling an estimated $257K and leaving 5,250 shares worth $1.9M. The position accounts for 0.34% of the portfolio, ranked #50.

DCF Advisers first reported a position in AMGN in Q4 2019 and has held it in 23 quarters since. The position peaked at $4.42M in Q4 2025. 3,153 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • DCF Advisers held 5,250 shares of Amgen worth $1.9M as of Q2 2026.
  • DCF Advisers sold 750 Amgen shares in Q2 2026, an estimated $257K.
  • Amgen made up 0.34% of DCF Advisers's portfolio in Q2 2026, its #50 holding.
  • DCF Advisers first reported a position in Amgen in Q4 2019 and has held it in 23 quarters since.
  • DCF Advisers's Amgen position peaked at $4.42M in Q4 2025.
  • 3,153 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on DCF Advisers's 13F filing for Q2 2026, filed 10 Aug 2026.